These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14764793)

  • 1. Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?
    Alenezi MY; Marcil M; Blank D; Sherman M; Genest J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):761-4. PubMed ID: 14764793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
    Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
    Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
    Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
    Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels.
    Eberhart GP; Mendez AJ; Freeman MW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):836-46. PubMed ID: 9506737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.
    Remaley AT; Schumacher UK; Stonik JA; Farsi BD; Nazih H; Brewer HB
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1813-21. PubMed ID: 9327782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
    Dullaart RP; Groen AK; Dallinga-Thie GM; de Vries R; Sluiter WJ; van Tol A
    Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.
    Francis GA; Knopp RH; Oram JF
    J Clin Invest; 1995 Jul; 96(1):78-87. PubMed ID: 7615839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects.
    Walter M; Gerdes U; Seedorf U; Assmann G
    Biochem Biophys Res Commun; 1994 Nov; 205(1):850-6. PubMed ID: 7999122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects.
    Fobker M; Voss R; Reinecke H; Crone C; Assmann G; Walter M
    FEBS Lett; 2001 Jul; 500(3):157-62. PubMed ID: 11445077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas.
    Schuler-Lüttmann S; Zhu Y; Hoffmann M; März W; Feussner G; Wieland H; Assmann G; von Eckardstein A
    Metabolism; 2000 Jun; 49(6):770-7. PubMed ID: 10877205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    de Vries R; Groen AK; Perton FG; Dallinga-Thie GM; van Wijland MJ; Dikkeschei LD; Wolffenbuttel BH; van Tol A; Dullaart RP
    Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome.
    Casella-Filho A; Chagas AC; Maranhão RC; Trombetta IC; Cesena FH; Silva VM; Tanus-Santos JE; Negrão CE; da Luz PL
    Am J Cardiol; 2011 Apr; 107(8):1168-72. PubMed ID: 21310370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women.
    Hsiao FC; Hsieh CH; Wu CZ; Hsu CH; Lin JD; Lee TI; Pei D; Chen YL
    Eur J Intern Med; 2013 Jul; 24(5):425-9. PubMed ID: 23647841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.